Insider Trading: Optimer Pharmaceuticals Inc (OPTR.O)

OPTR.O on Nasdaq

14.48USD
24 May 2013
Price Change (% chg)

$-0.19 (-1.30%)
Prev Close
$14.67
Open
$14.58
Day's High
$14.61
Day's Low
$14.30
Volume
422,811
Avg. Vol
1,001,729
52-wk High
$16.80
52-wk Low
$8.64

Search Stocks
ZERBE ROBERT L Options Exercised: 0
Trade Date: Monday, 31 Dec 2012 Price: 0.00
Title: Director Shares Held: 15,000
Type Traded: Direct Net Change in Shares This Filing: 7,500
» More Insider Trading

Institutional Holders

% Shares Owned: 90.53%
# of Holders: 136
Total Shares Held: 44,108,643
3 Mo. Net Change: 2,144,808
# New Positions: 20
# Closed Positions: 19
# Increased Positions: 62
# Reduced Positions: 56
# Net Buyers: 6

Officers & Directors

Name Age Since Current Position

Henry McKinnell

 70 2013 Chairman of the Board, Chief Executive Officer

Stephen Webster

 51 2012 Chief Financial Officer and Principal Financial and Accounting Officer

Eric Sirota

 51 2013 Chief Operating Officer

Sherwood Gorbach

 77 2011 Senior Vice President, Chief Scientific Officer

Linda Amper

 55 2011 Senior Vice President - Human Resources

Meredith Schaum

 2013 Chief Compliance Officer, General Counsel, Secretary

Mark Auerbach

 2013 Lead Independent Director

Michael Chang

 61 2012 Director

Stephen Newman

 62 2012 Director

Anthony Altig

 56 2007 Independent Director

Joseph Chang

 60 2012 Independent Director

Peter Grebow

 65 2009 Independent Director

Robert Zerbe

 61 2009 Independent Director

David Walsey

 VP - Investor Relations & Corporate Communications
Search Stocks